Related Experiment Video

Updated: May 23, 2026

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

Pre-infarction angina predicts thrombus burden in patients admitted for ST-segment elevation myocardial infarction

Tarek A N Ahmed1, Bastiaan J Sorgdrager, Suzanne C Cannegieter

  • 1Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
|April 24, 2012
PubMed

Insights

High thrombus grade in ST-elevation myocardial infarction (STEMI) is linked to larger infarct size and worse heart function. Absence of pre-infarction angina and proximal culprit lesions predict higher thrombus burden, informing treatment strategies.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomedical Science

Background:

  • High thrombotic burden in ST-elevation myocardial infarction (STEMI) can lead to distal embolization and myocardial no-reflow, potentially limiting the benefits of urgent revascularization.
  • Optimizing therapy to reduce thrombus burden is crucial for improving outcomes in STEMI patients undergoing primary percutaneous coronary intervention (PPCI).

Purpose of the Study:

  • To identify predictors of thrombus grade in STEMI patients undergoing PPCI.
  • To assess the relationship between thrombus grade and infarct size.
  • To optimize therapeutic strategies for reducing thrombus burden in STEMI.

Main Methods:

  • 153 consecutive STEMI patients undergoing PPCI were included.
  • Thrombus grade was assessed by angiography using the TIMI study group score, categorizing patients into high (HTG; score 4-5) and low (LTG; score 1-3) thrombus grade groups.
  • Predictors of HTG and infarct size (measured by peak CK, troponin T, and LVEF at 3 months) were evaluated using clinical, angiographic, and laboratory data.

Main Results:

  • 94 patients had HTG and 59 had LTG. Absence of pre-infarction angina (PIA) and proximal culprit lesions were independent predictors of HTG.
  • HTG was associated with higher peak CK and troponin T levels, and lower left ventricular ejection fraction (LVEF).
  • Pre-procedural TIMI flow was lower in the HTG group, and thrombosuction was more frequently applied.

Conclusions:

  • Absence of PIA and proximal culprit lesions are associated with higher thrombus grade in STEMI patients.
  • Higher thrombus grade correlates with larger infarct size and slightly worse LV function.
  • These findings have clinical implications for planning treatment strategies, including pharmacotherapy, to reduce thrombus burden before stent implantation.
Abstract

More Related Videos

Myocardial Infarction and Functional Outcome Assessment in Pigs12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Related Concept Videos

Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...